This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0227U for the Comprehensive Screen from Aspenti Health. The test provides detection of drugs and metabolites (break–down products) in the patient urine specimen to help prevent adverse drug interactions.
For clinical responsibility, terminology, tips and additional info
start codify free trial.